Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biliary atresia.

Barbara Anne Haber1, Pierre Russo

  • 1Division of Gastroenterology and Nutrition, Children's Hospital of Philadelphia, 34th and Civic Center Boulevard, Philadelphia, PA 19104, USA.

Gastroenterology Clinics of North America
|October 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breath volatile profiling reveals a diagnostic signature of MASLD in children.

medRxiv : the preprint server for health sciences·2026
Same author

Editor-in-Chief's Note.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same author

Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma.

Annals of hepatology·2025
Same author

Clinical Characteristics Associated With Variability in Biopsy Grade Severity of Liver Fibrosis in Fontan Circulation.

JACC. Advances·2025
Same author

Clinicopathologic Characterization of Liver Biopsies of Patients with Congenital Hyperinsulinism Presenting with Neonatal Cholestasis.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2025
Same author

Characterization of gallbladder disease in metachromatic leukodystrophy across the lifespan.

Molecular genetics and metabolism·2024
Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
See all related articles

Biliary Atresia (BA) significantly impacts pediatric hepatology as a leading cause of neonatal cholestasis and a primary reason for liver transplants. A new national initiative aims to improve BA treatment and understand its causes.

Area of Science:

  • Pediatric Hepatology
  • Neonatal Cholestasis
  • Liver Transplantation

Background:

  • Biliary Atresia (BA) is a rare disease with unknown causes.
  • It is the most frequent surgically correctable cause of neonatal cholestasis.
  • BA is the most common pediatric liver disease requiring transplantation.

Purpose of the Study:

  • To address the lack of progress in improving outcomes and understanding BA pathogenesis.
  • To introduce a new national, government-sponsored collaborative effort.
  • To drive advancements in BA treatment and pathogenesis research.

Main Methods:

  • A national, government-sponsored collaborative endeavor has been initiated.
  • Focus on designing new treatments for BA.
  • Emphasis on developing a better understanding of BA pathogenesis.

Related Experiment Videos

Main Results:

  • No specific results are detailed in the abstract.
  • The abstract highlights the initiation of a collaborative effort.
  • The expected impact on treatment and understanding is emphasized.

Conclusions:

  • BA remains a significant challenge in pediatric hepatology.
  • Current understanding and treatment outcomes for BA have seen limited progress.
  • A new national collaborative initiative holds promise for future advancements in BA research and patient care.